Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 62, No 1 (2011)
Review paper
Submitted: 2013-02-15
Published online: 2011-03-01
View PDF Download PDF file
Get Citation

Osteonecrosis of the jaw

Bogna Drozdzowska
Endokrynol Pol 2011;62(1):88-92.

open access

Vol 62, No 1 (2011)
Review Article
Submitted: 2013-02-15
Published online: 2011-03-01

Abstract

This review looks at osteonecrosis in the stomatognathic system (mainly the jaws). Osteonecrosis of the jaw (ONJ) is a rare but serious clinical condition. It affects patients treated with bisphosphonates, and also with denosumab, mainly in oncological doses. In osteoporosis, it is a problem of relatively small significance. Article presents a thorough review of this phenomenon, including its definition, pathogenesis, risk factors, prevention and treatment methods, and its incidence rate. (Pol J Endocrinol 2011; 62 (1): 88-92)

Abstract

This review looks at osteonecrosis in the stomatognathic system (mainly the jaws). Osteonecrosis of the jaw (ONJ) is a rare but serious clinical condition. It affects patients treated with bisphosphonates, and also with denosumab, mainly in oncological doses. In osteoporosis, it is a problem of relatively small significance. Article presents a thorough review of this phenomenon, including its definition, pathogenesis, risk factors, prevention and treatment methods, and its incidence rate. (Pol J Endocrinol 2011; 62 (1): 88-92)

Full Text:

View PDF Download PDF file
Get Citation

Keywords

osteonecrosis of the jaw; bisphosphonates; denosumab

About this article
Title

Osteonecrosis of the jaw

Journal

Endokrynologia Polska

Issue

Vol 62, No 1 (2011)

Article type

Review paper

Pages

88-92

Published online

2011-03-01

Page views

565

Article views/downloads

1368

Bibliographic record

Endokrynol Pol 2011;62(1):88-92.

Keywords

osteonecrosis of the jaw
bisphosphonates
denosumab

Authors

Bogna Drozdzowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl